What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus
Andrea W.M. Evers(Leiden University), Irving Kirsch(Harvard University), Jens Gaab(University of Basel), Fabrizio Benedetti(Department of Medical Sciences), Luana Colloca(University of Maryland, Baltimore), Karin Jensen(Karolinska Institutet), Karin Meißner(Coburg University of Applied Sciences), Christian Büchel(Universität Hamburg), Jeremy Howick(University of Oxford), Chris Beedie(University of Kent), Ionica Smeets(Leiden University), Lauren Y. Atlas(National Institutes of Health), Ben Colagiuri(The University of Sydney), Charlotte Blease(Uppsala University), Lene Vase(Aarhus University), Alia J. Crum(Stanford University), Damien G. Finniss(Royal North Shore Hospital), Andrew L. Geers(University of Toledo), Winfried Rief(Philipps University of Marburg), Vitaly Napadow(Spaulding Rehabilitation Hospital), Jet Bussemaker(Leiden University), Keith J. Petrie(University of Auckland), Regine Klinger(Universität Hamburg), Stefanie H. Meeuwis(Leiden University), Vishvarani Wanigasekera(University of Oxford), Ulrike Bingel(Essen University Hospital), John M. Kelley(Harvard University), Tor D. Wager(University of Colorado Boulder)
Cited by 98
Related Papers
Using social and behavioural science to support COVID-19 pandemic response
|Nature Human Behaviour|2020|5.1k
A meta-analysis of heart rate variability and neuroimaging studies: Implications for heart rate variability as a marker of stress and health
|Neuroscience & Biobehavioral Reviews|2011|3.1k
A classification of chronic pain for ICD-11
|Pain|2015|2.8k
Chronic pain: an update on burden, best practices, and new advances
|The Lancet|2021|2.4k